Intravenous Levodopa
Sponsors
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions
DyskinesiasParkinson DiseaseParkinson's Disease
Phase 2
Levetiracetam Treatment of L-dopa Induced Dyskinesias
CompletedNCT00076674
Start: 2004-01-31End: 2005-10-31Target: 40Updated: 2016-09-22
ACP-103 to Treat Parkinson's Disease
CompletedNCT00086294
Start: 2004-06-25End: 2007-11-15Target: 40Updated: 2017-07-02
Lisuride Patch to Treat Parkinson's Disease
CompletedNCT00089622
Start: 2004-08-04End: 2007-03-31Target: 40Updated: 2017-07-02